Emergent BioSolutions to Participate in Virtual Investor Conferences
08/18/2020 - 06:31 AM
GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences through the end of September 2020:
2020 NYSE Healthcare & Technology Investor Access Day August 18 – virtual one-on-one meetings only 2020 Three Part Advisors Virtual Midwest IDEAS Investor Conference August 27 – pre-recorded presentation available beginning at 8:00am eastern 2020 Wells Fargo Virtual Healthcare Conference September 9 – presentation at 8:00am easternRobert W. Baird 2020 Global Healthcare Conference September 10 – presentation at 2:35pm easternMorgan Stanley 18th Annual Global Healthcare Conference 2020 September 14 – presentation at 4:30pm easternCantor Virtual Global Healthcare Conference 2020 September 15 – presentation at 3:20pm eastern2020 Singular Research Compelling Values Webcall September 17 – presentation at 12:00pm eastern For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280burrowsr@ebsi.com
Media Contact: Miko B. Neri Senior Director, Global Communications & Public Affairs 240-631-3392nerim@ebsi.com
Emergent Biosolutions Inc
EBS Rankings
#5463 Ranked by Stock Gains
EBS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Gaithersburg
About EBS
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent